Drug interactions
Celecoxib + Sulindac
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Duplicate NSAID therapy increases risk of serious gastrointestinal bleeding/ulceration, acute kidney injury, and elevations in blood pressure/edema; avoid concurrent use.
Mechanism of action
Pharmacodynamic additive inhibition of COX-1/COX-2 reduces gastric mucosal protection and renal prostaglandin-mediated perfusion; no meaningful pharmacokinetic interaction expected.
Clinical management
Avoid concomitant use. If switching between agents, minimize or avoid overlap. If concurrent use is unavoidable, use the lowest effective doses for the shortest duration, add gastroprotection (e.g., PPI or misoprostol) for high GI-risk patients, and monitor blood pressure, renal function (SCr/BUN), and signs of GI bleeding.
Drug reference
References
- Celebrex (celecoxib) Prescribing Information — FDA Label
- Sulindac Prescribing Information — FDA Label
- Nonselective NSAIDs: Adverse effects and patient selection — UpToDate
- NSAIDs + NSAIDs interaction monograph — Lexicomp
Frequently asked questions
Can I take Celecoxib with Sulindac?
The interaction is rated: Major. Duplicate NSAID therapy increases risk of serious gastrointestinal bleeding/ulceration, acute kidney injury, and elevations in blood pressure/edema; avoid concurrent use.
How serious is the interaction between Celecoxib and Sulindac?
The interaction is rated: Major. Evidence level: High.
How is the interaction between Celecoxib and Sulindac managed?
Avoid concomitant use. If switching between agents, minimize or avoid overlap. If concurrent use is unavoidable, use the lowest effective doses for the shortest duration, add gastroprotection (e.g., PPI or misoprostol) for high GI-risk patients, and monitor blood pressure, renal function (SCr/BUN), and signs of GI bleeding.
Why do Celecoxib and Sulindac interact?
Pharmacodynamic additive inhibition of COX-1/COX-2 reduces gastric mucosal protection and renal prostaglandin-mediated perfusion; no meaningful pharmacokinetic interaction expected.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.